Gastroenterology O'Shea RS, Davitkov P et. al.
Sep 29th, 2021 - AGA Clinical Practice Guideline on the Management of Coagulation Disorders in Patients With Cirrhosis.|2021|O'Shea RS,Davitkov P,Ko CW,Rajasekhar A,Su GL,|
Gastroenterology Intagliata NM, Davitkov P et. al.
Sep 29th, 2021 - AGA Technical Review on Coagulation in Cirrhosis.|2021|Intagliata NM,Davitkov P,Allen AM,Falck-Ytter YT,Stine JG,|
Annals of Oncology : Official Journal of the European Soc... Casali PG, Blay JY et. al.
Sep 25th, 2021 - Gastrointestinal stromal tumours: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up.|2021|Casali PG,Blay JY,Abecassis N,Bajpai J,Bauer S,|
Gastrointestinal Endoscopy; Shah BJ, Onken JE et. al.
Sep 12th, 2021 - Development of gastroenterology and transplant hepatology milestones 2.0: a guide for programs, faculty, and fellows.|2021|Shah BJ,Onken JE,Edgar L,Jou JH,Obstein KL,|
Chest Rajamani A, Galarza L et. al.
Sep 12th, 2021 - With the paucity of high-quality studies on longitudinal basic critical care echocardiography (BCCE) training, expert opinion guidelines have guided BCCE competence educational standards and processes. However, existing guidelines lack precise detail due to methodological flaws during guideline development. To formulate methodologically robust guidelines on BCCE training using evidence and expe...
The Journal of Heart and Lung Transplantation : the Offic... Crespo MM, Claridge T et. al.
Sep 4th, 2021 - Patients with connective tissues disease (CTD) are often on immunomodulatory agents before lung transplantation (LTx). Till now, there's no consensus on the safety of using these agents perioperative and post-transplant. The International Society for Heart and Lung Transplantation-supported consensus document on LTx in patients with CTD addresses the risk and contraindications of perioperative ...
Gastroenterology Shah SC, Piazuelo MB et. al.
Aug 30th, 2021 - The purpose of this Clinical Practice Update Expert Review is to provide clinicians with guidance on the diagnosis and management of atrophic gastritis, a common preneoplastic condition of the stomach, with a primary focus on atrophic gastritis due to chronic Helicobacter pylori infection-the most common etiology-or due to autoimmunity. To date, clinical guidance for best practices related to t...
Annals of Oncology : Official Journal of the European Soc... Yoshino T, Argilés G et. al.
Aug 20th, 2021 - The most recent version of the European Society for Medical Oncology (ESMO) Clinical Practice Guidelines for the diagnosis, treatment and follow-up of localised colon cancer was published in 2020. It was decided by both the ESMO and the Japanese Society of Medical Oncology (JSMO) to convene a special virtual guidelines meeting in March 2021 to adapt the ESMO 2020 guidelines to take into account...
Gastrointestinal Endoscopy; Kwok K, Hasan N et. al.
Aug 18th, 2021 - American Society for Gastrointestinal Endoscopy radiation and fluoroscopy safety in GI endoscopy.|2021|Kwok K,Hasan N,Duloy A,Murad F,Nieto J,|
Gastrointestinal Endoscopy; Saumoy M, Yang J et. al.
Aug 5th, 2021 - Endoscopic management of acute cholecystitis has expanded in patients who are considered nonoperative candidates. Traditionally managed with percutaneous cholecystostomy (PC), improvement in techniques and devices has led to increased use of endoscopic methods for gallbladder drainage. This document reviews technical aspects of endoscopic transpapillary gallbladder drainage (ET-GBD) and EUS-gui...
Clinics and Research in Hepatology and Gastroenterology; Lemoinne S, Heurgue A et. al.
Aug 1st, 2021 - Autoimmune hepatitis (AIH) is a liver disease characterised by necrotico-inflammatory lesions of hepatocytes, the presence of specific autoantibodies and response to corticosteroid treatment. AIH must be considered in any patient with acute or chronic liver disease. As there is no pathognomonic sign of AIH, the diagnosis is based on a combination of clinical, biological, immunological and histo...
Clinics and Research in Hepatology and Gastroenterology; Thabut D, Weil D et. al.
Aug 1st, 2021 - Compensated advanced chronic liver disease (cACLD) describes the spectrum of advanced fibrosis/cirrhosis in asymptomatic patients at risk of developing clinically significant portal hypertension (CSPH, defined by a hepatic venous pressure gradient (HVPG) ≥10 mmHg). Patients with cACLD are at high risk of liver-related morbidity and mortality. In patients at risk of chronic liver disease, cACLD ...
Clinics and Research in Hepatology and Gastroenterology; Dumortier J, Besch C et. al.
Aug 1st, 2021 - The field of liver transplantation directly or indirectly embodies all liver diseases, in addition to specific ones related to organ rejection (cellular and humoral). The recommended non-invasive methods for determining the indication for liver transplantation are the Model for End-stage Liver Disease score, and the alpha-foetoprotein score in case of hepatocellular carcinoma. Radiological meth...
Clinics and Research in Hepatology and Gastroenterology; Tran A, Shili-Masmoudi S et. al.
Aug 1st, 2021 - Hepatitis C virus (HCV) infection is a major cause of chronic liver disease. Clinical care for patients with HCV-related liver disease has advanced considerably with developments in screening, diagnostic procedures to evaluate liver fibrosis and improvements in therapy with pangenotypic direct antivirals and prevention. These AFEF guidelines on the non-invasive diagnosis and follow up of chroni...
Clinics and Research in Hepatology and Gastroenterology; Leroy V, Chevaliez S et. al.
Aug 1st, 2021 - Diagnosis of chronic hepatitis B virus (HBV) infection, initial staging of infection and monitoring of treated and untreated patients are mainly based on clinical, biological and imaging criteria allowing a complete non-invasive management for the majority of patients. Along to the conventional virological tools, rapid diagnostic tests and blotting paper tests for HBV DNA are validated alternat...
Clinics and Research in Hepatology and Gastroenterology; Corpechot C, Heurgue A et. al.
Aug 1st, 2021 - Primary biliary cholangitis (PBC) is a chronic inflammatory disease of the intra-hepatic bile ducts (1). It is characterised biologically by chronic cholestasis associated with the presence of specific autoantibodies, and histologically by lesions of nonsuppurative destructive cholangitis. If left untreated it can progress to cirrhosis, portal hypertension and liver failure. Diagnosis, staging ...
Clinics and Research in Hepatology and Gastroenterology; Nahon P, Aubé C et. al.
Aug 1st, 2021 - Among a wide range of malignant liver tumours, hepatocellular carcinoma (HCC) developed on a background of cirrhosis represents the most frequent clinical situation. In this setting, HCC is one of the rare solid tumours for which histological confirmation is not mandatory. The convergence of multiple arguments obtained by non-invasive parameters using radiological findings allows to avoid liver...
Clinics and Research in Hepatology and Gastroenterology; Chazouillères O, Potier P et. al.
Aug 1st, 2021 - Primary sclerosing cholangitis (PSC) is a rare and chronic cholestatic liver disease of unknown cause commonly associated with inflammatory bowel disease (IBD) and characterized by progressive obliterative fibro-inflammation of the biliary tree. Although the natural course is highly variable, PSC is often progressive, leading to biliary cirrhosis and its complications. In addition, PSC is a con...
Gastrointestinal Endoscopy; , Law RJ et. al.
Jul 28th, 2021 - Lumen-apposing metal stents (LAMSs) are a novel class of devices that have expanded the spectrum of endoscopic GI interventions. LAMSs with their dumbbell configuration, short saddle length, and large inner luminal diameter provide favorable stent characteristics to facilitate anastomosis formation between the gut lumen and adjacent structures. The MEDLINE database was searched through April 20...
Journal of the European Academy of Dermatology and Venere... Rashid H, Lamberts A et. al.
Jul 11th, 2021 - This guideline on mucous membrane pemphigoid (MMP) has been elaborated by the Task Force for Autoimmune Blistering Diseases of the European Academy of Dermatology and Venereology (EADV) with a contribution of physicians from all relevant disciplines and patient organizations. It is a S3 consensus-based guideline encompassing a systematic review of the literature until June 2019 in the MEDLINE a...